ScopusElsevier Scopus
Status
Active
Coverage
1980–present
Source type
Journal
Open access
No
CiteScore
6.1
SJR · SCImago
1.020
Q1 SJR quartile
H-index
230
Best quartile
Q2 · 59th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cancer Research | 94 / 233 | 59th | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Carcinogenesis
Carcinogenesis is Scopus-indexed (Q2, CiteScore 6.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 0143-3334Verify ISSN ↗1460-2180Verify ISSN ↗
Publisher: Oxford University Press
Scopus · Q2WoS · SCIEONOS
6.1
CiteScore 2025
Q2
Best quartile
2
Indexed in
Cost to publish: About US$4,835 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Carcinogenesis indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1980–present, best quartile Q2, CiteScore 6.1.
What quartile is Carcinogenesis in Scopus?
Carcinogenesis is Q2 in Cancer Research (rank 94 of 233), by CiteScore 2025.
What is the impact factor of Carcinogenesis?
Carcinogenesis is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.1, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.020, quartile Q1, with an H-index of 230.
How much does it cost to publish in Carcinogenesis?
The publisher lists an article processing charge of about US$4,835 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Carcinogenesis and what is its ISSN?
Carcinogenesis is published by Oxford University Press. Its print ISSN is 0143-3334 and its online ISSN is 1460-2180.
Is Carcinogenesis covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Carcinogenesis in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Carcinogenesis open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Carcinogenesis? — open metrics via OpenAlex
Carcinogenesis has an h-index of 262 and a 2-year mean of 2.86 citations per paper (OpenAlex). Its Scopus CiteScore is 6.1, quartile Q2. On 2-year citations it ranks #101 of 229 Scopus journals in Cancer Research.
262
h-index
2.86
2-yr mean citations
11,145
i10-index
14,146
works indexed
731,096
total citations
Publication fee · open access list price, US$
US$4,835
2-yr mean citations, among Scopus journals in the same subject
#101 of 229 Top 45% Cancer Research
Carcinogenesis published 109 papers in 2025; its busiest recent year was 2017 with 226. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Carcinogenesis? — latest 95 articles, 2025–2026
In its latest 95 research articles (2025–2026), authors are most often from China (32.1%), United States (29.9%) and Japan (13.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Carcinogenesis? — indicators, not proof of misconduct
Scopus status: Active. 54 retracted papers are recorded (3.8 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 54 · 3.8 per 1,000 papers
- Problematic Paper Screener flags 2 · 0.1 per 1,000 papers — mostly suspect text and tortured phrases
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Cardiovascular Research Scopus Q1 WoS SCIE Cerebral Cortex Scopus Q1 WoS SCIE CESifo Economic Studies Scopus Q3 WoS SSCI ABDC C ABS 2 Chemical Senses Scopus Q3 WoS SCIE Chemistry Letters Scopus Q3 WoS SCIE Child Development Scopus Q1 WoS SSCI Child Development Perspectives Scopus Q1 WoS SSCI Chinese Journal of Comparative Law Scopus Q2 WoS ESCI
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.